Home
Arch Venture Fund IX Overage, 10% Owner: Lyell Immunopharma LYEL Buy · Filed 03/09
Trade details
- Type
- Insider buy
- Amount
- $12,499,984.9
- Shares · price
- 488,090 sh · $25.61 a share
- Held after
- 1,426,528 sh
- Trade date
- 26/03/06
- Filed
- 26/03/09
- Days to filing
- 3 days
First buy since 2023
- Insiders buying this week
- 14 insiders
- Holding change
- +52.0%
Lyell Immunopharma trades, last 26 weeks
What else happened in Lyell Immunopharma around then
Filed or reported within 30 days of the trade day · 02/04~04/05Arch Venture Fund IX Overage's recent trades
- Arch Venture Fund IX Overage
BuyBoundless Bio
BuyBoundless Bio
BOLD
$2.1M
133,333 sh
$2.1M
Filed 24/04/04
Traded 24/04/02
- Arch Venture Fund IX Overage
BuyBoundless Bio
BuyBoundless Bio
BOLD
$1.1M
66,667 sh
$1.1M
Filed 24/04/04
Traded 24/04/02
- Arch Venture Fund IX Overage
BuySana Biotechnology
BuySana Biotechnology
SANA
$4M
727,272 sh
$4M
Filed 24/02/12
Traded 24/02/08
- Arch Venture Fund IX Overage
BuySana Biotechnology
BuySana Biotechnology
SANA
$4M
727,272 sh
$4M
Filed 24/02/12
Traded 24/02/08
- Arch Venture Fund IX Overage
BuySana Biotechnology
BuySana Biotechnology
SANA
$2M
363,637 sh
$2M
Filed 24/02/12
Traded 24/02/08